3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
3
Lymphoma
3
Preleukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Esophageal Neoplasms
2
Bone Marrow Diseases
2
Sarcoma
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Interventions
Nivolumab
7
cemiplimab
6
Specimen Handling
5
HhAntag691
5
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
4
Biopsy
4
sonidegib
3
pembrolizumab
3
CTLA-4 Antigen
3
relatlimab
2
prednylidene
2
deltacortene
2
daromun
2
Surgical Procedures, Operative
2
Standard of Care
2
Prednisone
2
Observation
2
Aminolevulinic Acid
2
tocilizumab
1
talimogene laherparepvec
1
poly ICLC
1
flt3 ligand protein
1
X-Rays
1
Watchful Waiting
1
Vitamin D
1
Tomography, Optical Coherence
1
Therapeutics
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Basal Cell
×
Patient Reported Outcome Measures
×
1 year
×
Clear all
No trials found.